A Ted Talk on building a career, question of the week, PARP inhibitors update on long-term use, and GYOEDU PARP video, Early-Stage Cervical Cancer video, and GYOEDU study summary app launched
GYOEDU Study Summary App Privacy
Publications Update # 143
Lack of menopause treatments in cancer survivors. Video tutorial on the Management of a WHO score 5 or 6 low-risk GTN and genetic referral in endometrial cancer in patients aged < 50 years.
Fulvestrant + Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer (NCT03643510)
GROINSS-V I: Sentinel Node Dissection as Sole Groin Staging in Early-Stage Vulvar Cancer
EMPOWER-Cervical 1 (GOG-3016 / ENGOT-cx9): Cemiplimab vs. Chemotherapy in Recurrent/Metastatic Cervical Cancer
PORTEC-4a: Molecular Profile-Based Adjuvant Treatment for High-Intermediate Risk Endometrial Cancer
AtTEnd: Atezolizumab plus Chemotherapy for Advanced or Recurrent Endometrial Cancer
SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis)
AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer